Vitro Biopharma Introduces New Products for Personalized Cellular Medicine MarketWatch (press release) ... to study potential treatment of various conditions including, Type I & II diabetes, Parkinson's disease, organ transplant rejection, osteoarthritis, MS, spinal cord injury, stroke, myocardial infarction, cardiovascular disease, liver degeneration, ... |
